{"id":"W2144510249","doi":"10.1177/1753465812452193","title":"New treatment options for multidrug-resistant tuberculosis","year":2012,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Tuberculosis; Isoniazid; Rifabutin; Linezolid; Intensive care medicine; Drug resistance; Mycobacterium tuberculosis; Rifampicin; Drug; Multiple drug resistance; Extensively drug-resistant tuberculosis; Adverse effect; Pyrazinamide; Public health; Pharmacology; Internal medicine; Microbiology; Pathology; Clarithromycin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005105763,0.0007703116,0.002516625,0.0005106601,0.0001321511,0.00001944464,0.0002872706,0.0003240116,0.0002735874],"category_scores_gemma":[0.0002483425,0.0005409481,0.001227306,0.0004212238,0.0001730282,0.0002209723,0.00005884596,0.0003907242,0.0001692209],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00104562,"about_ca_system_score_gemma":0.001517139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002526118,"about_ca_topic_score_gemma":0.00005996566,"domain_scores_codex":[0.9960582,0.0006104221,0.001079236,0.0008215134,0.0003182723,0.001112417],"domain_scores_gemma":[0.9960956,0.001048411,0.0002829838,0.001048032,0.00007490454,0.001450075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005866807,0.0005224195,0.0002286076,0.007887465,0.0004012574,0.00003536028,0.00002192409,0.000009035283,0.000002225078,0.0008357279,0.0001763093,0.989293],"study_design_scores_gemma":[0.001744179,0.00052043,0.0003222493,0.002949554,0.003333986,0.000004843452,0.00001686294,0.00001973324,0.000001164753,0.0003598346,0.9902611,0.0004660311],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001109206,0.994269,0.000443184,0.000240948,0.000266048,0.00399721,0.0004010788,0.00009170597,0.0002797818],"genre_scores_gemma":[0.00004426596,0.9933237,0.0009088859,0.0008030478,0.0009215535,0.002848607,0.0003048755,0.0001418608,0.0007031344],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9900848,"threshold_uncertainty_score":0.9997042,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1483258399282707,"score_gpt":0.4590051209546901,"score_spread":0.3106792810264195,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}